Milgamma (Benfotiamine, Cyanocobalamin)

Benfotiamine and Cyanocobalamin, the active ingredients in Milgamma, are vitamin supplements presented as an oral tablet for oral use. They are intended to support nerve health and address deficiencies of vitamin B1 and B12, particularly in diabetic peripheral neuropathy and related nerve pain. GNH USA supplies Milgamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Milgamma is a nutritional supplement that targets metabolic and neurological pathways associated with vitamin B1 and B12 deficiencies and diabetic nerve disorders.

Diabetic peripheral neuropathy: supports nerve function and may alleviate pain associated with diabetic nerve damage. Peripheral nerve pain: contributes to symptom relief in non‑diabetic neuropathic conditions. Vitamin B1 (thiamine) deficiency: restores thiamine levels essential for carbohydrate metabolism. Vitamin B12 (cobalamin) deficiency: provides cobalamin needed for DNA synthesis and neuronal maintenance.

Milgamma is generally well tolerated, but some users may experience mild adverse reactions.

Common Side Effects: - Nausea or mild stomach upset. - Headache. - Dizziness. - Transient skin rash or itching. - Altered taste perception. - Mild fatigue.

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reactions. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Significant hematologic abnormalities such as pancytopenia. - Severe neuropathy worsening. - Acute liver injury. - Unexplained swelling of the face, lips, or tongue.

Before starting Milgamma, consider the following precautions: - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: use only if advised by a physician. - Renal impairment: monitor renal function and adjust therapy as needed. - Concomitant medications: review all current drugs for potential interactions. - Known hypersensitivity: avoid if you have experienced allergic reactions to benfotiamine, cyanocobalamin, or any excipients. - Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Milgamma may interact with certain medications; awareness of these interactions helps maintain safety.

Major Interactions (Avoid): - Antimetabolite chemotherapy agents (e.g., methotrexate): may reduce the effectiveness of cyanocobalamin. - High‑dose folic acid therapy: can mask hematologic signs of B12 deficiency.

Moderate Interactions (Monitor Closely): - Metformin: may exacerbate B12 deficiency, requiring periodic monitoring. - Proton pump inhibitors or H2 blockers: can decrease B12 absorption. - Alcohol use: may increase risk of neuropathy and diminish vitamin benefits. - Other B‑vitamin supplements: may lead to excessive intake and gastrointestinal upset.